6-K/A

POSITIVE RESULTS FROM BRODALUMAB PHASE III STUDY

Company: ASTRAZENECA PLC
Filed: November 26, 2014
Period of Report: November 26, 2014
Accession Number: 0001191638-14-001509

View Document ↗ View on SEC.gov ↗